The Manufacturer and Distributor Perspective on Building Supply Chain Resiliency (Re-engineering the Health Care Supply Chain: CQO Thought Leader Discussion Series)

AHRMM Webinar Image

 

Price: Member: FREE  |  Non-Member: $49.00

CEC Hours: 1

Order Webinar

  

Re-engineering the Health Care Supply Chain: A CQO Thought Leader Discussion Series” is hosted by AHRMM's Cost, Quality and Outcomes (CQO) Movement sponsors. This webinar series focuses on how the health care supply chain will evolve and be more resilient in the post-pandemic environment.

The resiliency of the health care supply chain is interdependent upon the resiliency of the manufacturer and distributor supply chain. In the first webinar of the series, distributor and manufacturer panelists discuss their changing strategies relating to COVID-19 lessons, domestic versus international production and ways providers, distributors and manufacturers need to work together moving forward.

For future webinars in this series, visit the AHRMM Calendar.

 

Moderator: Karen Conway, Vice President, Healthcare Value, GHX

Panelists:

  • Christine Arme, Vice President Healthcare Systems & Strategic Channels, Medical Solutions Division, 3M Health Care Business Group
  • Lisa Hohman, CEO, Concordance Healthcare Solutions
  • Ruben Taborda, Senior Director, Hospital and Distributor Supply Chain Solutions, Johnson & Johnson

 

Download the Survey Results

Download the Summary

 

 

Sponsored By:

CQO Sponsors

Related Resources

Advisory
The medical device excise tax is a feature of the Affordable Care Act. It is important to be knowledgeable about the tax and its effects.
Toolkits/Methodology
The Strategic Marketplace Initiative (SMI) is a consortium of healthcare supply c
Request for Proposals (RFP)
A sample of wholesale pharmacy distributor request for proposal.
Letter/Comment
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Fo
Toolkits/Methodology
How-to guide to managing IV disruptions.
Advisory
The final regulations that provide guidance on the excise tax imposed on the sale of certain medical devices, enacted by the Health Care and Educ